semaglutide addictive behavior 🔥 "What if a weight-loss drug could help treat addiction? Researchers are investigating exactly that.", Recent research suggests that medications like may influence the brain's reward GLP-1 Weight-Loss Drugs Could Address

High bilirubin levels, known as hyperbilirubinaemia, can indicate liver dysfunction, such as hepatitis, cirrhosis, or bile duct obstruction

Dulaglutide ameliorates palmitic acid-induced hepatic steatosis by activating FAM3A signaling pathway

We also thank Johanna Welch, PhD, and Angela Harper, PhD, who provided medical writing services on behalf of Novo Nordisk A/S

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with specific FDA-approved indications: Ozempic and Rybelsus for type 2 diabetes management, and Wegovy specifically for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity